Literature DB >> 28185892

Lack of Patient-Clinician Concordance in Cancer Patients: Its Relation With Patient Variables.

Kavita D Chandwani1, Fengmin Zhao2, Gary R Morrow3, Teresa L Deshields4, Lori M Minasian5, Judith Manola2, Michael J Fisch6.   

Abstract

CONTEXT: Patients with cancer are bothered by its diagnosis, treatment, and associated uncertainty. Lack of concordance (LOC) of patients' reporting of their symptoms and quality of life (QOL) with that of their clinicians has been observed in cancer care. However, information regarding the reporting of patients' bother due to aspects of cancer experience and their clinicians' assessment is lacking.
OBJECTIVES: The objective was to describe cancer patients' bother due to aspects of their disease experience and explore the concordance (LOC) or a lack thereof between patients' and clinicians' reporting of patients' bother and factors associated with it.
METHODS: Data from a prospective study of cancer patients' symptoms were analyzed. LOC was defined as any discrepancy between patient-clinician pairs in reporting patients' bother due to disease, cancer treatment, comorbidity, and side effects of symptom management. The relation of LOC to patients' QOL and distress was also explored.
RESULTS: Of the 2597 patients analyzed, a perfect concordance was observed in 37%-42%. Clinicians underestimated the severity of bother in 62%-76% of discordant cases. LOC was significantly associated with patient-reported distress and poor QOL. Referral for symptom management was associated with the clinician's rating of patients' bother, and LOC was associated with likelihood of poor compliance with recommendations for symptom management.
CONCLUSION: Majority of clinicians tended to underestimate cancer patients' bother, and this was associated with poor QOL of cancer patients and their distress. Future studies should examine the LOC and its correlates to confirm the results of this study.
Copyright © 2017 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lack of concordance; QOL; bother; cancer; distress; treatment compliance

Mesh:

Year:  2017        PMID: 28185892      PMCID: PMC5474148          DOI: 10.1016/j.jpainsymman.2016.12.347

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  35 in total

1.  A comparison of patient and proxy symptom assessments in advanced cancer patients.

Authors:  C L Nekolaichuk; E Bruera; K Spachynski; T MacEachern; J Hanson; T O Maguire
Journal:  Palliat Med       Date:  1999-07       Impact factor: 4.762

Review 2.  Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review.

Authors:  C A Jackson; J Clatworthy; A Robinson; Rob Horne
Journal:  Am J Gastroenterol       Date:  2009-12-08       Impact factor: 10.864

3.  Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

Authors:  C S Cleeland; T R Mendoza; X S Wang; C Chou; M T Harle; M Morrissey; M C Engstrom
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

4.  Perception of quality of life by patients, partners and treating physicians.

Authors:  K A Wilson; A J Dowling; M Abdolell; I F Tannock
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

5.  Assessment of quality of life in outpatients with advanced cancer: the accuracy of clinician estimations and the relevance of spiritual well-being--a Hoosier Oncology Group Study.

Authors:  Michael J Fisch; Michael L Titzer; Jean L Kristeller; Jianzhao Shen; Patrick J Loehrer; Sin-Ho Jung; Steven D Passik; Lawrence H Einhorn
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

6.  Proxy assessment of quality of life in patients with prostate cancer: how accurate are partners and urologists?

Authors:  R Pearcy; D Waldron; C O'Boyle; R MacDonagh
Journal:  J R Soc Med       Date:  2008-03       Impact factor: 5.344

7.  Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer.

Authors:  Mary H Sailors; Diane C Bodurka; Ibrahima Gning; Lois M Ramondetta; Loretta A Williams; Tito R Mendoza; Sonika Agarwal; Charlotte C Sun; Charles S Cleeland
Journal:  Gynecol Oncol       Date:  2013-05-15       Impact factor: 5.482

8.  Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia.

Authors:  Richard-Olivier Fourcade; François Lacoin; Morgan Rouprêt; Alain Slama; Camille Le Fur; Emilie Michel; Axel Sitbon; François-Emery Cotté
Journal:  World J Urol       Date:  2011-09-03       Impact factor: 4.226

9.  How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling?

Authors:  W Söllner; A DeVries; E Steixner; P Lukas; G Sprinzl; G Rumpold; S Maislinger
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640

10.  Factors affecting therapeutic compliance: A review from the patient's perspective.

Authors:  Jing Jin; Grant Edward Sklar; Vernon Min Sen Oh; Shu Chuen Li
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

View more
  11 in total

1.  Fatigue among patients with renal cell carcinoma receiving adjuvant sunitinib or sorafenib: patient-reported outcomes of ECOG-ACRIN E2805 trial.

Authors:  Fengmin Zhao; David Cella; Judith Manola; Robert S DiPaola; Lynne I Wagner; Naomi S B Haas
Journal:  Support Care Cancer       Date:  2017-12-23       Impact factor: 3.603

2.  Comparing Parent and Child Self-report Measures of the State-Trait Anxiety Inventory in Children and Adolescents with a Chronic Health Condition.

Authors:  Lindsey M Shain; Maryland Pao; Mary V Tipton; Sima Zadeh Bedoya; Sun J Kang; Lisa M Horowitz; Lori Wiener
Journal:  J Clin Psychol Med Settings       Date:  2020-03

3.  Disagreement between patient- and physician-reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.

Authors:  Akira Ooki; Satoshi Morita; Akihito Tsuji; Shigeyoshi Iwamoto; Hiroki Hara; Hiroaki Tanioka; Hironaga Satake; Masato Kataoka; Masahito Kotaka; Yoshinori Kagawa; Masato Nakamura; Tatsushi Shingai; Masashi Ishikawa; Yasuhiro Miyake; Takeshi Suto; Yojiro Hashiguchi; Taichi Yabuno; Masahiko Ando; Junichi Sakamoto; Kensei Yamaguchi
Journal:  Cancer Med       Date:  2020-11-21       Impact factor: 4.452

4.  Assessing health-related quality of life in Chinese children and adolescents with cancer: validation of the DISABKIDS chronic generic module (DCGM-37).

Authors:  Hasan Alelayan; Lizhu Liang; Rui Ye; Jiangnan Meng; Xiaoyan Liao
Journal:  BMC Cancer       Date:  2021-02-27       Impact factor: 4.430

5.  Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study.

Authors:  Yeh Chen Lee; Madeleine T King; Rachel L O'Connell; Anne Lanceley; Florence Joly; Felix Hilpert; Alison Davis; Felicia T Roncolato; Aikou Okamoto; Jane Bryce; Paul Donnellan; Amit M Oza; Elisabeth Avall-Lundqvist; Jonathan S Berek; Jonathan A Ledermann; Dominique Berton; Jalid Sehouli; Amanda Feeney; Marie-Christine Kaminsky; Katrina Diamante; Martin R Stockler; Michael L Friedlander
Journal:  Int J Gynecol Cancer       Date:  2022-06-06       Impact factor: 4.661

6.  Patient and clinician nudges to improve symptom management in advanced cancer using patient-generated health data: study protocol for the PROStep randomised controlled trial.

Authors:  Ravi B Parikh; William Ferrell; Jonathan Wakim; Joelle Williamson; Neda Khan; Michael Kopinsky; Mohan Balachandran; Peter E Gabriel; Yichen Zhang; Lynn M Schuchter; Lawrence N Shulman; Jinbo Chen; Mitesh S Patel; Christopher R Manz
Journal:  BMJ Open       Date:  2022-05-12       Impact factor: 3.006

7.  Patient-reported outcomes in head and neck cancer: prospective multi-institutional patient-reported toxicity.

Authors:  M Sean Peach; Daniel M Trifiletti; Carolyn Vachani; Karen Arnold-Korzeniowski; Christina Bach; Margaret Hampshire; James M Metz; Christine E Hill-Kayser
Journal:  Patient Relat Outcome Meas       Date:  2018-07-27

8.  Matters of data openness and KapWeb, a web tool of multi-cancer survival analysis for cancer survivors.

Authors:  Jason Lin; Yohko Nakamura; Haruo Mikami; Miho Kusakabe; Nobuhiro Saruki; Fumihiko Wakao; Hiroki Nagase
Journal:  Cancer Sci       Date:  2021-03-10       Impact factor: 6.716

9.  Evaluation by electronic patient-reported outcomes of cancer survivors' needs and the efficacy of inpatient cancer rehabilitation in different tumor entities.

Authors:  Thomas Licht; Alain Nickels; Gerhard Rumpold; Bernhard Holzner; David Riedl
Journal:  Support Care Cancer       Date:  2021-03-23       Impact factor: 3.603

10.  What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer.

Authors:  Emma Dunlop; Aimee Ferguson; Tanja Mueller; Kelly Baillie; Julie Clarke; Jennifer Laskey; Amanj Kurdi; Olivia Wu; Rob Jones; Hilary Glen; Marion Bennie
Journal:  Support Care Cancer       Date:  2021-12-08       Impact factor: 3.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.